Lipid-lowering effect of atorvastatin in heart transplantation

被引：4
|
作者：
Bonet, LA [1 ]
Martínez-Dolz, L [1 ]
Vives, MAA [1 ]
Soriano, JR [1 ]
Sáez, AO [1 ]
Gisbert, FD [1 ]
Pérez, MP [1 ]
机构：
[1] Hosp Univ La Fe, Dept Cardiol, Valencia, Spain
来源：
TRANSPLANTATION PROCEEDINGS | 2002年 / 34卷 / 01期
关键词：
D O I：
10.1016/S0041-1345(01)02718-X
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：179 / +
页数：4
相关论文
共 50 条
  • [1] Lipid-lowering efficacy of atorvastatin
    Adams, Stephen P.
    Tsang, Michael
    Wright, James M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (03):
  • [2] The lipid-lowering effect of atorvastatin in Taiwanese diabetic patients with hyperlipidemia
    Chang, Chwen-Tzuei
    Lee, Jenn-Kuen
    Lin, Jen-Der
    Hung, Yi-Jen
    Liu, Rue-Tsuan
    Shau, Wen-Yi
    Sheu, Wayne Huey-Herng
    [J]. TZU CHI MEDICAL JOURNAL, 2013, 25 (03): : 168 - 174
  • [3] The Lipid-Lowering Effect of Atorvastatin in Acute Coronary Syndrome Patients
    Ying, Ku Ming
    Tan, S. S. N.
    Tan, C. S. Y.
    Tiong, L. L.
    Lim, A. M. W.
    Ling, D. E.
    Hii, E. H. H.
    Kiu, I. S. N.
    Wong, L. W.
    Ting, M. L. L.
    Sumbai, M. E.
    Chua, A. T. P.
    Douglas, J. S.
    Theng, M. L.
    Chew, S. W.
    Fong, A. Y. Y.
    Ong, T. K.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 273 : 7 - 8
  • [4] The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin
    Mbarki, S.
    Abdesselem, S.
    Kallel, A.
    Jemaa, R.
    Rekik, B.
    Jamaa, M.
    Kaabechi, N.
    Mechmeche, R.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 370 - 370
  • [5] Markers of heart failure and lipid-lowering effect of atorvastatin in patients with myocardial infarction with ST segment elevation
    Oleinikov, Valentin
    Barmenkova, Y.
    Dushina, E.
    Burko, N.
    Galimskaya, V.
    Golubeva, A.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 72 - 72
  • [6] Atorvastatin: beyond lipid-lowering effects in the diabetic population
    Ramos, Julie
    Khan, Qamar A.
    Thoenes, Martin
    Khan, Bobby V.
    [J]. FUTURE CARDIOLOGY, 2006, 2 (05) : 527 - 533
  • [7] Safety and tolerability of lipid-lowering drugs after heart transplantation: The heart transplant lipid registry
    Ballantyne, CM
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 1997, 3 : S74 - S76
  • [8] Lipid-lowering and antiaggregatory efficacy of atorvastatin in coronary heart disease patients with combined hyperlipidemia
    Viigimaa, M
    Välkman, R
    [J]. ATHEROSCLEROSIS, 1999, 144 : 24 - 24
  • [9] Effects of lipid-lowering treatment with atorvastatin on endothelial function in patients with ischaemic heart failure
    Antoniades, C
    Tousoulis, D
    Brilli, S
    Tentolouris, C
    Marinou, K
    Pitsavos, C
    Stefanadis, C
    Toutouzas, P
    [J]. EUROPEAN HEART JOURNAL, 2002, 23 : 418 - 418
  • [10] The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate
    Christidis, Dimitrios S.
    Liberopoulos, Evangelos N.
    Kakafika, Anna I.
    Miltiadous, George A.
    Cariolou, Marios
    Ganotakis, Emmanuel S.
    Mikhailidis, Dimitri P.
    Elisaf, Moses S.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2006, 11 (03) : 211 - 221
12345